Review



anti fatp1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems anti fatp1
    Anti Fatp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm40752427-72-10-11?v=R%26D+Systems
    Average 93 stars, based on 6 article reviews
    anti fatp1 - by Bioz Stars, 2026-08
    93/100 stars

    Images



    Similar Products

    94
    OriGene anti slc27a1 primary antibody
    Anti Slc27a1 Primary Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm42168271-372-10-13?v=OriGene
    Average 94 stars, based on 1 article reviews
    anti slc27a1 primary antibody - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    93
    R&D Systems anti fatp1
    Anti Fatp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm40752427-72-10-11?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti fatp1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    96
    Proteintech fatp1
    Figure 2. Cellular uptake of Ce6-pTP-CsA. a) Representative CLSM images and f) analysis of MFI showing the cellular uptake of BODIPY-stained Ce6- pTP-CsA co-incubated with A375-M1 cells for 12 h, 24 h, and 48 h (n = 3). Scale bar: 50 μm. b,c) Western blot analysis of <t>FATP1,</t> FABP4, and CD36 expression in A375-M1 cells treated with PBS, PA, pTP, and Ce6-pTP-CsA (n = 3). d) CLSM and g) MFI analysis of Ce6 uptake in A375-M1 cells for 3, 12, and 24 h (n = 3). Scale bar: 20 μm (n = 3). e) FCM analysis of Ce6 uptake in A375-M1 cells for different durations (n = 3). (ns, not significant; **p < 0.01; ***p < 0.001; ****p < 0.0001).
    Fatp1, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm39804941-243-7-16?v=Proteintech
    Average 96 stars, based on 1 article reviews
    fatp1 - by Bioz Stars, 2026-08
    96/100 stars
      Buy from Supplier

    90
    ABclonal Biotechnology anti-fatp1 antibody abclonal wh342075
    Effect of PTE on placental nutrient transport capacity. A – C Fatty acid transporter <t>FATP1</t> and glucose transporter GLUT3, 200× analysis of IF staining. Data are expressed as mean ± SD ( n = 3 for each group). * P < 0.05, compared to the control group
    Anti Fatp1 Antibody Abclonal Wh342075, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pmc11456245-82-0-2?v=ABclonal+Biotechnology
    Average 90 stars, based on 1 article reviews
    anti-fatp1 antibody abclonal wh342075 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher antibody anti-fatp1 (slc27a1)
    Effect of PTE on placental nutrient transport capacity. A – C Fatty acid transporter <t>FATP1</t> and glucose transporter GLUT3, 200× analysis of IF staining. Data are expressed as mean ± SD ( n = 3 for each group). * P < 0.05, compared to the control group
    Antibody Anti Fatp1 (Slc27a1), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm37843714-36-0-10?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    antibody anti-fatp1 (slc27a1) - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    R&D Systems antibodies targeting anti fatp1
    FIGURE 3 Transcript level of fatty acid transporters, i.e., CD36/SR-B2 (A), <t>FATP1</t> (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status. Data are presented as mean ± SD. Values are expressed in arbitrary units, i.e., lean non-targeting siRNA group was set at 1 [AU]. # Difference between the cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non-targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.
    Antibodies Targeting Anti Fatp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm37602323-102-9-15?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    antibodies targeting anti fatp1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-fatp1
    FIGURE 3 Transcript level of fatty acid transporters, i.e., CD36/SR-B2 (A), <t>FATP1</t> (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status. Data are presented as mean ± SD. Values are expressed in arbitrary units, i.e., lean non-targeting siRNA group was set at 1 [AU]. # Difference between the cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non-targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.
    Anti Fatp1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm36063868-83-32-38?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    anti-fatp1 - by Bioz Stars, 2026-08
    90/100 stars
      Buy from Supplier

    93
    R&D Systems fatp1
    FIGURE 3 Transcript level of fatty acid transporters, i.e., CD36/SR-B2 (A), <t>FATP1</t> (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status. Data are presented as mean ± SD. Values are expressed in arbitrary units, i.e., lean non-targeting siRNA group was set at 1 [AU]. # Difference between the cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non-targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.
    Fatp1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+fatp1/pm36100608-375-3-6?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    fatp1 - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    Image Search Results


    Figure 2. Cellular uptake of Ce6-pTP-CsA. a) Representative CLSM images and f) analysis of MFI showing the cellular uptake of BODIPY-stained Ce6- pTP-CsA co-incubated with A375-M1 cells for 12 h, 24 h, and 48 h (n = 3). Scale bar: 50 μm. b,c) Western blot analysis of FATP1, FABP4, and CD36 expression in A375-M1 cells treated with PBS, PA, pTP, and Ce6-pTP-CsA (n = 3). d) CLSM and g) MFI analysis of Ce6 uptake in A375-M1 cells for 3, 12, and 24 h (n = 3). Scale bar: 20 μm (n = 3). e) FCM analysis of Ce6 uptake in A375-M1 cells for different durations (n = 3). (ns, not significant; **p < 0.01; ***p < 0.001; ****p < 0.0001).

    Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

    Article Title: Cryoshocked Adipocytes Mediated Dual-Modal Strategy Combining Photodynamic Therapy and Triptolide Palmitate for Pulmonary Metastatic Melanoma Treatment.

    doi: 10.1002/advs.202414307

    Figure Lengend Snippet: Figure 2. Cellular uptake of Ce6-pTP-CsA. a) Representative CLSM images and f) analysis of MFI showing the cellular uptake of BODIPY-stained Ce6- pTP-CsA co-incubated with A375-M1 cells for 12 h, 24 h, and 48 h (n = 3). Scale bar: 50 μm. b,c) Western blot analysis of FATP1, FABP4, and CD36 expression in A375-M1 cells treated with PBS, PA, pTP, and Ce6-pTP-CsA (n = 3). d) CLSM and g) MFI analysis of Ce6 uptake in A375-M1 cells for 3, 12, and 24 h (n = 3). Scale bar: 20 μm (n = 3). e) FCM analysis of Ce6 uptake in A375-M1 cells for different durations (n = 3). (ns, not significant; **p < 0.01; ***p < 0.001; ****p < 0.0001).

    Article Snippet: The antibodies used for Western blotting, including FATP1, FABP4, CD36, CHOP, and ATF4, were obtained from Proteintech (IL, USA); P-elF2α and Bcl-2 primary antibodies were from Abclonal (MA, USA); the PERK primary antibody was from Servicebio (Wuhan, China); and the Cleaved PARP, Cleaved-Caspase 3, and CleavedCaspase 9 primary antibodies were from CST (MA, USA).

    Techniques: Staining, Incubation, Western Blot, Expressing

    Effect of PTE on placental nutrient transport capacity. A – C Fatty acid transporter FATP1 and glucose transporter GLUT3, 200× analysis of IF staining. Data are expressed as mean ± SD ( n = 3 for each group). * P < 0.05, compared to the control group

    Journal: Journal of Animal Science and Biotechnology

    Article Title: Dietary supplementation with pterostilbene activates the PI3K-AKT-mTOR signalling pathway to alleviate progressive oxidative stress and promote placental nutrient transport

    doi: 10.1186/s40104-024-01090-9

    Figure Lengend Snippet: Effect of PTE on placental nutrient transport capacity. A – C Fatty acid transporter FATP1 and glucose transporter GLUT3, 200× analysis of IF staining. Data are expressed as mean ± SD ( n = 3 for each group). * P < 0.05, compared to the control group

    Article Snippet: Anti-FATP1 antibody (Abclonal WH342075) was purchased from Abclonal (Wuhan, China).

    Techniques: Staining, Control

    FIGURE 3 Transcript level of fatty acid transporters, i.e., CD36/SR-B2 (A), FATP1 (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status. Data are presented as mean ± SD. Values are expressed in arbitrary units, i.e., lean non-targeting siRNA group was set at 1 [AU]. # Difference between the cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non-targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.

    Journal: Frontiers in molecular biosciences

    Article Title: RabGAP AS160/TBC1D4 deficiency increases long-chain fatty acid transport but has little additional effect on obesity and metabolic syndrome in ADMSCs-derived adipocytes of morbidly obese women.

    doi: 10.3389/fmolb.2023.1232159

    Figure Lengend Snippet: FIGURE 3 Transcript level of fatty acid transporters, i.e., CD36/SR-B2 (A), FATP1 (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status. Data are presented as mean ± SD. Values are expressed in arbitrary units, i.e., lean non-targeting siRNA group was set at 1 [AU]. # Difference between the cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non-targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.

    Article Snippet: The acquired ADMSCs were subjected to staining with monoclonal antibodies targeting anti-FATP1 (ACSVL5; mouse anti-human) (R&D Systems), anti-FATP4 (ACSVL4; rabbit anti-human), and anti-CD36/SR-B2 (CD36/SR-B2; rabbit antihuman) (Abcam).

    Techniques: Transfection, Negative Control, Knockdown

    FIGURE 4 Total protein abundance of fatty acid transporters, i.e., CD36/SR-B2 (A), FATP1 (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status. Data are presented as mean ± SD. # Difference between cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non-targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.

    Journal: Frontiers in molecular biosciences

    Article Title: RabGAP AS160/TBC1D4 deficiency increases long-chain fatty acid transport but has little additional effect on obesity and metabolic syndrome in ADMSCs-derived adipocytes of morbidly obese women.

    doi: 10.3389/fmolb.2023.1232159

    Figure Lengend Snippet: FIGURE 4 Total protein abundance of fatty acid transporters, i.e., CD36/SR-B2 (A), FATP1 (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status. Data are presented as mean ± SD. # Difference between cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non-targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.

    Article Snippet: The acquired ADMSCs were subjected to staining with monoclonal antibodies targeting anti-FATP1 (ACSVL5; mouse anti-human) (R&D Systems), anti-FATP4 (ACSVL4; rabbit anti-human), and anti-CD36/SR-B2 (CD36/SR-B2; rabbit antihuman) (Abcam).

    Techniques: Quantitative Proteomics, Transfection, Negative Control, Knockdown

    FIGURE 5 Plasma membrane abundance of fatty acid transporters, i.e., CD36/SR-B2 (A), FATP1 (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status evaluated by flow cytometry analysis. Data are presented as mean ± SD. # Difference between the cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non- targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.

    Journal: Frontiers in molecular biosciences

    Article Title: RabGAP AS160/TBC1D4 deficiency increases long-chain fatty acid transport but has little additional effect on obesity and metabolic syndrome in ADMSCs-derived adipocytes of morbidly obese women.

    doi: 10.3389/fmolb.2023.1232159

    Figure Lengend Snippet: FIGURE 5 Plasma membrane abundance of fatty acid transporters, i.e., CD36/SR-B2 (A), FATP1 (B), and FATP4 (C) in AS160 knocked down mature adipocytes differentiated from ADMSCs of patients with different metabolic status evaluated by flow cytometry analysis. Data are presented as mean ± SD. # Difference between the cells transfected with siRNA targeting AS160 and scrambled siRNA (negative control) within the metabolic status of the donor patient; p < 0.05; n = 4 for each study group (measurements taken in duplicate). Designations of the groups: NC, negative control containing non- targeting siRNA fragment; siAS160, knockdown of AS160; obese (−), obese without metabolic syndrome; and obese (+), obese with metabolic syndrome.

    Article Snippet: The acquired ADMSCs were subjected to staining with monoclonal antibodies targeting anti-FATP1 (ACSVL5; mouse anti-human) (R&D Systems), anti-FATP4 (ACSVL4; rabbit anti-human), and anti-CD36/SR-B2 (CD36/SR-B2; rabbit antihuman) (Abcam).

    Techniques: Clinical Proteomics, Membrane, Cytometry, Transfection, Negative Control, Knockdown